By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MDx Health today announced a deal with Newcastle University in the UK, Cancer Research Technology, and Pfizer to identify and develop biomarkers that can predict response to a PARP inhibitor.
Registering provides access to this and other free content.
Already have an account?Login Now.
The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.
The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.
Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.
In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.